Results 31 to 40 of about 1,180,314 (222)

Ebola virus

open access: yesUirusu, 2019
<p>Ebola virus (EBOV) is a member of the Filoviridae family of highly pathogenic viruses that cause severe hemorrhagic fever and is the causative agent of the 2014 West Africa outbreak. Currently, there are no approved filovirus vaccines or treatments to combat these sporadic and deadly epidemics. One target for EBOV antiviral therapy is to block
Bethany Ann Rhein   +5 more
openaire   +2 more sources

Ebola Virus Antibody Prevalence in Dogs and Human Risk

open access: yesEmerging Infectious Diseases, 2005
During the 2001–2002 outbreak in Gabon, we observed that several dogs were highly exposed to Ebola virus by eating infected dead animals. To examine whether these animals became infected with Ebola virus, we sampled 439 dogs and screened them by Ebola ...
Loïs Allela   +8 more
doaj   +1 more source

Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. [PDF]

open access: yes, 2003
We conducted two antibody surveys to assess risk factors for Marburg hemorrhagic fever in an area of confirmed Marburg virus transmission in the Democratic Republic of the Congo.
Roth, Cathy   +64 more
core   +1 more source

A comparative computational genomics of Ebola Virus Disease strains: In-silico Insight for Ebola control

open access: yesInformatics in Medicine Unlocked, 2018
Ebola Virus Disease (EVD), is a national epidemic in Countries affected. It is also a potential global public health pandemic. The menace of the disease outbreak among West and Central African nations, in recent years, has resulted in the death of many ...
Olugbenga Oluwagbemi, Olaitan Awe
doaj   +1 more source

Ebola virus indication.

open access: yes, 2019
Ebola virus indication.
Aslan Tchamkerten (6656066)   +4 more
core   +3 more sources

Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro

open access: yesMolecular Therapy: Nucleic Acids, 2019
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed against Ebola virus.
Anne Sadewasser   +9 more
doaj   +1 more source

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [PDF]

open access: yes, 2015
Emerging viral diseases pose a threat to the global population as intervention strategies are mainly limited to basic containment due to the lack of efficacious and approved vaccines and antiviral drugs.
Temperton, Nigel J.   +24 more
core   +1 more source

Ebola viral selenoproteins: a metallomics analysis

open access: yesAsian Pacific Journal of Tropical Biomedicine, 2015
Ebola virus infection is the present public health problem. The trend of worldwide epidemic becomes the serious consideration for this infection. The Ebola virus infection has main clinical manifestation as acute febrile illness with hemorrhagic episode.
Somsri Wiwanitkit, Viroj Wiwanitkit
doaj   +1 more source

Knowledge and risk perceptions of the Ebola virus in the United States

open access: yesPreventive Medicine Reports, 2015
Objectives: The Ebola epidemic has received extensive media coverage since the first diagnosed cases of the virus in the US. We investigated risk perceptions of Ebola among individuals living in the US and measured their knowledge of the virus.
Jonathan J. Rolison, Yaniv Hanoch
doaj   +1 more source

External Quality Assessment of Molecular Detection of Ebola Virus in China. [PDF]

open access: yesPLoS ONE, 2015
In 2014, Ebola hemorrhagic fever broke out in West Africa. As contact between China and West Africa is frequent, the possibility that Ebola virus would enter China was high.
Guojing Wang   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy